Biosafety considerations in handling medically important fungi

A. A. Padhye, J. E. Bennett, M. R. McGinnis, L. Sigler, A. Flis, I. F. Salkin

Research output: Contribution to journalArticle

Abstract

Over 500,000 workers in the USA alone are employed in laboratories that range from small physician offices to large clinical laboratories handling microbes for comprehensive research and/or diagnostic work. These workers are exposed to a variety of potential occupational health risks such as exposure to infectious clinical materials, environmental specimens, cultures, complex and inflammable chemicals, radiation, and electrical and mechanical hazards. As members of the International Society for Human and Animal Mycology, we have no policy statement on biosafety standards for handling medically important fungi. The intent of the symposium is to cover some of the important aspects of biosafety; (1) standards in handling dimorphic fungal pathogens; (2) the principles and criteria of biosafety levels and classification of known medically important fungi, aerobic actinomycetes, environmental fungi according to their biosafety levels; (3) medically important fungal waste and its safe disposal; and (4) biosafety and regulatory considerations in handling and mailing medically important fungi in a culture collection.

Original languageEnglish (US)
Pages (from-to)258-265
Number of pages8
JournalJournal of Medical and Veterinary Mycology
Volume3
StatePublished - 1998
Externally publishedYes

Fingerprint

Fungi
Mycology
Physicians' Offices
Actinobacteria
Occupational Health
Radiation
Research

Keywords

  • Biosafety principles
  • Fungal waste disposal
  • Mailing of pathogenic fungi
  • Medically important fungi

ASJC Scopus subject areas

  • Microbiology

Cite this

Padhye, A. A., Bennett, J. E., McGinnis, M. R., Sigler, L., Flis, A., & Salkin, I. F. (1998). Biosafety considerations in handling medically important fungi. Journal of Medical and Veterinary Mycology, 3, 258-265.

Biosafety considerations in handling medically important fungi. / Padhye, A. A.; Bennett, J. E.; McGinnis, M. R.; Sigler, L.; Flis, A.; Salkin, I. F.

In: Journal of Medical and Veterinary Mycology, Vol. 3, 1998, p. 258-265.

Research output: Contribution to journalArticle

Padhye, AA, Bennett, JE, McGinnis, MR, Sigler, L, Flis, A & Salkin, IF 1998, 'Biosafety considerations in handling medically important fungi', Journal of Medical and Veterinary Mycology, vol. 3, pp. 258-265.
Padhye AA, Bennett JE, McGinnis MR, Sigler L, Flis A, Salkin IF. Biosafety considerations in handling medically important fungi. Journal of Medical and Veterinary Mycology. 1998;3:258-265.
Padhye, A. A. ; Bennett, J. E. ; McGinnis, M. R. ; Sigler, L. ; Flis, A. ; Salkin, I. F. / Biosafety considerations in handling medically important fungi. In: Journal of Medical and Veterinary Mycology. 1998 ; Vol. 3. pp. 258-265.
@article{0cc4989ca1f049f281ac82581577a2d5,
title = "Biosafety considerations in handling medically important fungi",
abstract = "Over 500,000 workers in the USA alone are employed in laboratories that range from small physician offices to large clinical laboratories handling microbes for comprehensive research and/or diagnostic work. These workers are exposed to a variety of potential occupational health risks such as exposure to infectious clinical materials, environmental specimens, cultures, complex and inflammable chemicals, radiation, and electrical and mechanical hazards. As members of the International Society for Human and Animal Mycology, we have no policy statement on biosafety standards for handling medically important fungi. The intent of the symposium is to cover some of the important aspects of biosafety; (1) standards in handling dimorphic fungal pathogens; (2) the principles and criteria of biosafety levels and classification of known medically important fungi, aerobic actinomycetes, environmental fungi according to their biosafety levels; (3) medically important fungal waste and its safe disposal; and (4) biosafety and regulatory considerations in handling and mailing medically important fungi in a culture collection.",
keywords = "Biosafety principles, Fungal waste disposal, Mailing of pathogenic fungi, Medically important fungi",
author = "Padhye, {A. A.} and Bennett, {J. E.} and McGinnis, {M. R.} and L. Sigler and A. Flis and Salkin, {I. F.}",
year = "1998",
language = "English (US)",
volume = "3",
pages = "258--265",
journal = "Medical Mycology",
issn = "1369-3786",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Biosafety considerations in handling medically important fungi

AU - Padhye, A. A.

AU - Bennett, J. E.

AU - McGinnis, M. R.

AU - Sigler, L.

AU - Flis, A.

AU - Salkin, I. F.

PY - 1998

Y1 - 1998

N2 - Over 500,000 workers in the USA alone are employed in laboratories that range from small physician offices to large clinical laboratories handling microbes for comprehensive research and/or diagnostic work. These workers are exposed to a variety of potential occupational health risks such as exposure to infectious clinical materials, environmental specimens, cultures, complex and inflammable chemicals, radiation, and electrical and mechanical hazards. As members of the International Society for Human and Animal Mycology, we have no policy statement on biosafety standards for handling medically important fungi. The intent of the symposium is to cover some of the important aspects of biosafety; (1) standards in handling dimorphic fungal pathogens; (2) the principles and criteria of biosafety levels and classification of known medically important fungi, aerobic actinomycetes, environmental fungi according to their biosafety levels; (3) medically important fungal waste and its safe disposal; and (4) biosafety and regulatory considerations in handling and mailing medically important fungi in a culture collection.

AB - Over 500,000 workers in the USA alone are employed in laboratories that range from small physician offices to large clinical laboratories handling microbes for comprehensive research and/or diagnostic work. These workers are exposed to a variety of potential occupational health risks such as exposure to infectious clinical materials, environmental specimens, cultures, complex and inflammable chemicals, radiation, and electrical and mechanical hazards. As members of the International Society for Human and Animal Mycology, we have no policy statement on biosafety standards for handling medically important fungi. The intent of the symposium is to cover some of the important aspects of biosafety; (1) standards in handling dimorphic fungal pathogens; (2) the principles and criteria of biosafety levels and classification of known medically important fungi, aerobic actinomycetes, environmental fungi according to their biosafety levels; (3) medically important fungal waste and its safe disposal; and (4) biosafety and regulatory considerations in handling and mailing medically important fungi in a culture collection.

KW - Biosafety principles

KW - Fungal waste disposal

KW - Mailing of pathogenic fungi

KW - Medically important fungi

UR - http://www.scopus.com/inward/record.url?scp=33747093992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747093992&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 258

EP - 265

JO - Medical Mycology

JF - Medical Mycology

SN - 1369-3786

ER -